Report cover image

APAC Radiopharmaceuticals Market - Industry Trends and Forecast to 2030

Publisher Data Bridge Market Research
Published Jun 01, 2023
Length 278 Pages
SKU # DAABD18055234

Description

APAC Radiopharmaceuticals Market - Industry Trends and Forecast to 2030


The Asia-Pacific radiopharmaceuticals market is expected to reach USD 2,733.43 million by 2030 from USD 1,756.76 million in 2022, growing at a CAGR of 5.7% during the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation
Asia-Pacific Radiopharmaceuticals Market, By Type (Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals), Application (Diagnostic and Therapeutic), Source (Nuclear reactors and Cyclotrons), End User (Hospitals, Diagnostic Centers, Cancer research institutes, Ambulatory surgical centers, and Others), Country (China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific) - Industry Trends and Forecast to 2030

Overview of Asia-Pacific Radiopharmaceuticals Market Dynamics

Driver
• Growing demand for radiopharmaceutical among diagnostics and clinical use

Restraint

• Potential risks associated with radiopharmaceuticals
Opportunity

• Rising research and development expenditure of radiopharmaceuticals

Market Players

Some of the major market players operating in the Asia-Pacific radiopharmaceuticals market are:

• Cardinal Health
• Advanced Accelerator Applications, A Novartis Company
• Lantheus
• Curium Inc
• GENERAL ELECTRIC COMPANY
• Jubliant Radiopharma, A Jubilant Pharma Company
• China lsotope & Radiation Corporation
• Bracco
• NTP
• Eckert & Ziegler
• SHINE Technologies, LLC
• Eczacıbaşı-Monrol
• IBA Worldwide
• Global Medical Solutions
• BWX Technologies. Inc
• Institute of Isotopes
• Coqui Radiopharmaceuticals Corp,
• Evergreen Theragnostics, Inc.
• Isotope JSC
• PharmaLogic Holdings Corp
• Siemens Healthcare GmBH

Table of Contents

278 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The Asia Pacific Radiopharmaceuticals Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Product Type Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Market Testing Type Coverage Grid
2.11 Vendor Share Analysis
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porter’s Five Forces
4.3 Pipeline Analysis
4.4 Patent Analysis
4.5 Drug Treatment Rate By Matured Markets
4.6 Demographic Trends: Impacts On All Incidence Rates
4.7 Patient Flow Diagram
4.8 Key Pricing Strategies
4.9 Key Patient Enrollment Strategies
5 List Of Cyclotrons
6 Regulatory Scenario
6.1 Asia-pacific
7 Market Overview
7.1 Drivers
7.1.1 The Growing Demand For Radiopharmaceuticals In Diagnostics And Clinical Use
7.1.2 The Increasing Need For Pharmaceutical Products Across Varied Therapeutic Areas
7.1.3 The Increasing Prevalence Of Chronic Diseases
7.2 Restraints
7.2.1 Stringent Regulations For Radiopharmaceuticals
7.2.2 Potential Risks Associated With Radiopharmaceuticals
7.3 Opportunities
7.3.1 The Rising Research And Development Expenditure Of Radiopharmaceuticals
7.3.2 The Growing Incidences Of Complex Diseases In Geriatric Population
7.4 Challenges
7.4.1 High Cost Of Development And Implementation Of Radiopharmaceuticals
7.4.2 Lack Of Technical Expertise And High Cost For Training Existing Workforce
8 Asia Pacific Radiopharmaceuticals Market, By Type
8.1 Overview
8.2 Diagnostic Radiopharmaceuticals
8.2.1 Pet Radiopharmaceuticals
8.2.1.1 F-18
8.2.1.2 Ru-82
8.2.1.3 Other Pet Isotopes Radiopharmaceuticals
8.2.2 Spect Radiopharmaceuticals
8.2.2.1 Technetium-99m
8.2.2.2 Gallium-67
8.2.2.3 Iodine-123
8.2.2.4 Thallium-201
8.2.2.5 Other Spect Isotopes
8.3 Therapeutic Radiopharmaceuticals
8.3.1 Brachytherapy Isotopes
8.3.1.1 Iodine-125
8.3.1.2 Palladium-103
8.3.1.3 Cesium-131
8.3.1.4 Iridium-192
8.3.1.5 Other Brachytherapy Isotopes
8.3.2 Beta Emitters
8.3.2.1 Iodine-131
8.3.2.2 Luthetium-177
8.3.2.3 Samarium-153
8.3.2.4 Yttrium-90
8.3.2.5 Rhenium-186
8.3.2.6 Other Beta Emitters
8.3.3 Alpha Emitters
8.3.3.1 Ra-223
8.3.3.2 Others
9 Asia Pacific Radiopharmaceuticals Market, By Application
9.1 Overview
9.2 Diagnostic
9.2.1 Pet
9.2.1.1 Oncology
9.2.1.2 Cardiology
9.2.1.3 Neurology
9.2.1.4 Other Pet Application
9.2.2 Spect
9.2.2.1 Cardiology
9.2.2.2 Bone Scans
9.2.2.3 Thyroid Applications
9.2.2.4 Pulmonary Scans
9.2.2.5 Other Spect Application
9.3 Therapeutic
9.3.1 Thyroid Indications
9.3.2 Bone Metastasis
9.3.3 Lymphoma
9.3.4 Endocrine Tumors
9.3.5 Other Indications
10 Asia Pacific Radiopharmaceuticals Market, By Source
10.1 Overview
10.2 Nuclear Reactors
10.3 Cyclotrons
11 Asia Pacific Radiopharmaceuticals Market, By End User
11.1 Overview
11.2 Hospitals
11.3 Diagnostic Centers
11.4 Cancer Research Institutes
11.5 Ambulatory Surgical Centers
11.6 Others
12 Asia Pacific Radiopharmaceuticals Market, By Region
12.1 Asia Pacific
12.1.1 China
12.1.2 Australia
12.1.3 Japan
12.1.4 South Korea
12.1.5 Singapore
12.1.6 India
12.1.7 Indonesia
12.1.8 Philippines
12.1.9 Thailand
12.1.10 Malaysia
12.1.11 Vietnam
12.1.12 Rest Of Asia-pacific
13 Asia Pacific Radiopharmaceuticals Market: Company Landscape
13.1 Company Share Analysis: Asia Pacific
14 Swot Analysis
15 Company Profile
15.1 Cardinal Health
15.1.1 Company Snapshot
15.1.2 Revenue Analysis
15.1.3 Company Share Analysis
15.1.4 Product Portfolio
15.1.5 Recent Development
15.2 Advanced Accelerator Applications, A Novartis Company
15.2.1 Company Snapshot
15.2.2 Revenue Analysis
15.2.3 Company Share Analysis
15.2.4 Product Portfolio
15.2.5 Recent Development
15.3 Lantheus
15.3.1 Company Snapshot
15.3.2 Revenue Analysis
15.3.3 Company Share Analysis
15.3.4 Product Portfolio
15.3.5 Recent Development
15.4 Curium
15.4.1 Company Snapshot
15.4.2 Company Share Analysis
15.4.3 Product Portfolio
15.4.4 Recent Development
15.5 General Electric Company
15.5.1 Company Snapshot
15.5.2 Revenue Analysis
15.5.3 Company Share Analysis
15.5.4 Product Portfolio
15.5.5 Recent Development
15.6 Bracco
15.6.1 Company Snapshot
15.6.2 Product Portfolio
15.6.3 Recent Development
15.7 Bwx Technologies. Inc.
15.7.1 Company Snapshot
15.7.2 Revenue Analysis
15.7.3 Product Portfolio
15.7.4 Recent Development
15.8 China Isotope & Radiation Corporation
15.8.1 Company Snapshot
15.8.2 Revenue Analysis
15.8.3 Product Portfolio
15.8.4 Recent Development
15.9 Coqui Radiopharmaceuticals Corp.
15.9.1 Company Snapshot
15.9.2 Product Portfolio
15.9.3 Recent Development
15.10 Eckert & Ziegler
15.10.1 Company Snapshot
15.10.2 Revenue Analysis
15.10.3 Product Portfolio
15.10.4 Recent Development
15.11 Eczacibaşi-monrol
15.11.1 Company Snapshot
15.11.2 Product Portfolio
15.11.3 Recent Development
15.12 Evergreen Theragnostics, Inc.
15.12.1 Company Snapshot
15.12.2 Product Portfolio
15.12.3 Recent Development
15.13 Asia Pacific Medical Solutions
15.13.1 Company Snapshot
15.13.2 Product Portfolio
15.13.3 Recent Development
15.14 Iba Worldwide
15.14.1 Company Snapshot
15.14.2 Revenue Analysis
15.14.3 Product Portfolio
15.14.4 Recent Development
15.15 Institute Of Isotopes
15.15.1 Company Snapshot
15.15.2 Product Portfolio
15.15.3 Recent Development
15.16 Isotope Jsc
15.16.1 Company Snapshot
15.16.2 Product Portfolio
15.16.3 Recent Development
15.17 Jubilant Radiopharma A Jubilant Pharmova Company
15.17.1 Company Snapshot
15.17.2 Revenue Analysis
15.17.3 Product Portfolio
15.17.4 Recent Development
15.18 Ntp
15.18.1 Company Snapshot
15.18.2 Product Portfolio
15.18.3 Recent Development
15.19 Pharmalogic Holdings Corp
15.19.1 Company Snapshot
15.19.2 Product Portfolio
15.19.3 Recent Development
15.20 Shine Technologies, Llc
15.20.1 Company Snapshot
15.20.2 Product Portfolio
15.20.3 Recent Development
15.21 Siemens Healthcare Gmbh
15.21.1 Company Snapshot
15.21.2 Revenue Analysis
15.21.3 Product Portfolio
15.21.4 Recent Development
16 Questionnaire
17 Related Reports
List Of Tables
Table 1 Asia Pacific Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 2 Asia Pacific Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Region, 2021-2030 (Usd Million)
Table 3 Asia Pacific Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 4 Asia Pacific Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 5 Asia Pacific Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 6 Asia Pacific Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Region, 2021-2030 (Usd Million)
Table 7 Asia Pacific Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 8 Asia Pacific Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 9 Asia Pacific Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 10 Asia Pacific Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 11 Asia Pacific Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 12 Asia Pacific Diagnostic In Radiopharmaceuticals Market, By Region, 2021-2030 (Usd Million)
Table 13 Asia Pacific Diagnostic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 14 Asia Pacific Pet In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 15 Asia Pacific Spect In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 16 Asia Pacific Therapeutic In Radiopharmaceuticals Market, By Region, 2021-2030 (Usd Million)
Table 17 Asia Pacific Therapeutic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 18 Asia Pacific Radiopharmaceuticals Market, By Source, 2021-2030 (Usd Million)
Table 19 Asia Pacific Nuclear Reactors In Radiopharmaceuticals Market, By Region, 2021-2030 (Usd Million)
Table 20 Asia Pacific Cyclotrons In Radiopharmaceuticals Market, By Region, 2021-2030 (Usd Million)
Table 21 Asia Pacific Radiopharmaceuticals Market, By End User, 2021-2030 (Usd Million)
Table 22 Asia Pacific Hospitals In Radiopharmaceuticals Market, By Region, 2021-2030 (Usd Million)
Table 23 Asia Pacific Diagnostic Centers In Radiopharmaceuticals Market, By Region, 2021-2030 (Usd Million)
Table 24 Asia Pacific Cancer Research Institutes In Radiopharmaceuticals Market, By Region, 2021-2030 (Usd Million)
Table 25 Asia Pacific Ambulatory Surgical Centers In Radiopharmaceuticals Market, By Region, 2021-2030 (Usd Million)
Table 26 Asia Pacific Others In Radiopharmaceuticals Market, By Region, 2021-2030 (Usd Million)
Table 27 Asia-pacific Radiopharmaceuticals Market, By Country, 2021-2030 (Usd Million)
Table 28 Asia-pacific Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 29 Asia-pacific Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 30 Asia-pacific Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 31 Asia-pacific Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 32 Asia-pacific Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 33 Asia-pacific Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 34 Asia-pacific Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 35 Asia-pacific Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 36 Asia-pacific Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 37 Asia-pacific Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 38 Asia-pacific Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 39 Asia-pacific Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 40 Asia-pacific Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 41 Asia-pacific Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 42 Asia-pacific Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 43 Asia-pacific Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 44 Asia-pacific Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 45 Asia-pacific Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 46 Asia-pacific Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 47 Asia-pacific Diagnostic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 48 Asia-pacific Pet In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 49 Asia-pacific Spect In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 50 Asia-pacific Therapeutic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 51 Asia-pacific Radiopharmaceuticals Market, By Source, 2021-2030 (Usd Million)
Table 52 Asia-pacific Radiopharmaceuticals Market, By End User, 2021-2030 (Usd Million)
Table 53 China Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 54 China Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 55 China Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 56 China Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 57 China Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 58 China Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 59 China Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 60 China Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 61 China Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 62 China Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 63 China Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 64 China Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 65 China Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 66 China Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 67 China Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 68 China Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 69 China Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 70 China Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 71 China Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 72 China Diagnostic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 73 China Pet In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 74 China Spect In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 75 China Therapeutic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 76 China Radiopharmaceuticals Market, By Source, 2021-2030 (Usd Million)
Table 77 China Radiopharmaceuticals Market, By End User, 2021-2030 (Usd Million)
Table 78 Australia Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 79 Australia Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 80 Australia Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 81 Australia Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 82 Australia Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 83 Australia Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 84 Australia Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 85 Australia Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 86 Australia Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 87 Australia Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 88 Australia Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 89 Australia Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 90 Australia Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 91 Australia Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 92 Australia Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 93 Australia Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 94 Australia Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 95 Australia Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 96 Australia Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 97 Australia Diagnostic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 98 Australia Pet In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 99 Australia Spect In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 100 Australia Therapeutic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 101 Australia Radiopharmaceuticals Market, By Source, 2021-2030 (Usd Million)
Table 102 Australia Radiopharmaceuticals Market, By End User, 2021-2030 (Usd Million)
Table 103 Japan Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 104 Japan Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 105 Japan Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 106 Japan Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 107 Japan Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 108 Japan Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 109 Japan Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 110 Japan Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 111 Japan Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 112 Japan Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 113 Japan Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 114 Japan Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 115 Japan Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 116 Japan Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 117 Japan Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 118 Japan Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 119 Japan Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 120 Japan Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 121 Japan Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 122 Japan Diagnostic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 123 Japan Pet In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 124 Japan Spect In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 125 Japan Therapeutic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 126 Japan Radiopharmaceuticals Market, By Source, 2021-2030 (Usd Million)
Table 127 Japan Radiopharmaceuticals Market, By End User, 2021-2030 (Usd Million)
Table 128 South Korea Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 129 South Korea Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 130 South Korea Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 131 South Korea Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 132 South Korea Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 133 South Korea Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 134 South Korea Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 135 South Korea Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 136 South Korea Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 137 South Korea Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 138 South Korea Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 139 South Korea Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 140 South Korea Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 141 South Korea Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 142 South Korea Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 143 South Korea Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million)
Table 144 South Korea Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq)
Table 145 South Korea Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq)
Table 146 South Korea Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 147 South Korea Diagnostic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 148 South Korea Pet In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
Table 149 South Korea Spect In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million)
List Of Figures
Figure 1 Asia Pacific Radiopharmaceuticals: Segmentation
Figure 2 Asia Pacific Radiopharmaceuticals Market: Data Triangulation
Figure 3 Asia Pacific Radiopharmaceuticals Market: Droc Analysis
Figure 4 Asia Pacific Radiopharmaceuticals Market: Asia Pacific Vs Regional Market Analysis
Figure 5 Asia Pacific Radiopharmaceuticals Market: Company Research Analysis
Figure 6 Asia Pacific Radiopharmaceuticals Market: Interview Demographics
Figure 7 Asia Pacific Radiopharmaceuticals Market: Dbmr Market Position Grid
Figure 8 Asia Pacific Radiopharmaceuticals Market: Market Testing Type Coverage Grid
Figure 9 Asia Pacific Radiopharmaceuticals Market: Vendor Share Analysis
Figure 10 Asia Pacific Radiopharmaceuticals Market: Segmentation
Figure 11 The Rising Prevalence Of Chronic Diseases Is Expected To Drive The Asia Pacific Radiopharmaceuticals Market In The Forecast Period
Figure 12 The Type Segment Is Expected To Account For The Largest Share Of The Asia Pacific Radiopharmaceuticals Market In 2023 & 2030
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The Asia Pacific Radiopharmaceuticals Market
Figure 14 Asia Pacific Radiopharmaceuticals Market: By Type, 2022
Figure 15 Asia Pacific Radiopharmaceuticals Market: By Type, 2023-2030 (Usd Million)
Figure 16 Asia Pacific Radiopharmaceuticals Market: By Type, Cagr (2023-2030)
Figure 17 Asia Pacific Radiopharmaceuticals Market: By Type, Lifeline Curve
Figure 18 Asia Pacific Radiopharmaceuticals Market: By Application, 2022
Figure 19 Asia Pacific Radiopharmaceuticals Market: By Application, 2023-2030 (Usd Million)
Figure 20 Asia Pacific Radiopharmaceuticals Market: By Application, Cagr (2023-2030)
Figure 21 Asia Pacific Radiopharmaceuticals Market: By Application, Lifeline Curve
Figure 22 Asia Pacific Radiopharmaceuticals Market: By Source, 2022
Figure 23 Asia Pacific Radiopharmaceuticals Market: By Source, 2023-2030 (Usd Million)
Figure 24 Asia Pacific Radiopharmaceuticals Market: By Source, Cagr (2023-2030)
Figure 25 Asia Pacific Radiopharmaceuticals Market: By Source, Lifeline Curve
Figure 26 Asia Pacific Radiopharmaceuticals Market: By End User, 2022
Figure 27 Asia Pacific Radiopharmaceuticals Market: By End User, 2023-2030 (Usd Million)
Figure 28 Asia Pacific Radiopharmaceuticals Market: By End User, Cagr (2023-2030)
Figure 29 Asia Pacific Radiopharmaceuticals Market: By End User, Lifeline Curve
Figure 30 Asia-pacific Radiopharmaceuticals Market: Snapshot (2022)
Figure 31 Asia-pacific Radiopharmaceuticals Market: By Country (2022)
Figure 32 Asia-pacific Radiopharmaceuticals Market: By Country (2023 & 2030)
Figure 33 Asia-pacific Radiopharmaceuticals Market: By Country (2022 & 2030)
Figure 34 Asia-pacific Radiopharmaceuticals Market: By Type (2023-2030)
Figure 35 Asia Pacific Radiopharmaceuticals Market: Company Share 2022 (%) 197

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us